EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrated histopathological and molecular diagnostics reveal substantial diagnostic shifts in pediatric melanocytic tumors

Michael Abele, Matthias Hahn, Gisela Metzler, Ulla Graeßner, Maja Haar, Thomas K Eigentler, Andrea Forschner iD, Nadja Ballin, Christopher Schroeder, Dominik T Schneider, Ines B Brecht iD, Stephan Forchhammer iD

JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 05.11.2026

DOI: 10.1111/ddg.70541 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, online erschienen am 05.11.2026. Verfasst von Michael Abele und 11 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Hematology/Oncology, Department of Pediatrics, University Hospital Tübingen, Tübingen, Germany. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Childhood Cancer Foundation, Deutsche Kinderkrebsstiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and objectives Pediatric melanocytic tumors are rare and biologically heterogeneous. Distinguishing melanomas from Spitz‐lineage tumors based on histomorphology alone is challenging and may lead to inadequate treatment. We aimed to characterize melanocytic tumors in pediatric patients enrolled in the German STEP registry and to assess changes in diagnosis after centralized integrated pathology review. Patients and methods We analyzed patients ≤ 18 years with melanocytic tumors registered in STEP (2021–2025) who underwent centralized review. Histopathological and immunohistochemical findings were integrated with molecular analyses. Local diagnoses were compared with final referral diagnoses.

Results

Thirty‐five patients were included; molecular analyses were necessary in 29 cases (83%). After centralized review and integrated diagnostics, 16 tumors (46%) were reclassified. Fusion‐defined Spitz‐lineage tumors increased from 14% at local diagnosis to 40%. Among patients ≤ 10 years, none of the tumors initially diagnosed as conventional melanoma retained this diagnosis. After centralized review, 14 cases were diagnosed as melanoma and one case as clear cell sarcoma. Fatal outcomes were documented in 5 patients with melanoma. All remaining patients were alive without evidence of disease progression at last follow‐up.

Conclusions

Centralized integrated diagnostics improves classification of pediatric melanocytic tumors and may help to avoid unnecessary invasive diagnostics or therapy while ensuring accurate identification of melanoma.

Schlagwörter

Stichwörter der Autor:innen

Histopathologymelanocytic tumormelanomamolecular diagnosticspediatric cancer

Autor:innen und Institutionen

  • Pediatric Hematology/Oncology, Department of Pediatrics, University Hospital Tübingen, Tübingen, Germany.
  • Center for Dermatooncology, Department of Dermatology, University Hospital Tübingen, Tübingen, Germany.
  • Zentrum für Dermatohistologie und Oralpathologie Tübingen/Würzburg, Tübingen, Germany.
  • Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen, Tübingen, Germany.
  • Clinic of Pediatrics, Klinikum Dortmund, University Witten/Herdecke, Dortmund, Germany.

ORCID-Profile: Andrea Forschner, Ines B Brecht, Stephan Forchhammer

Förderung

  • German Childhood Cancer Foundation
  • Deutsche Kinderkrebsstiftung

Zitieren

APA

Abele, M., Hahn, M., Metzler, G., Graeßner, U., Haar, M., Eigentler, T. K., Forschner, A., Ballin, N., Schroeder, C., Schneider, D. T., Brecht, I. B., & Forchhammer, S. (2026). Integrated histopathological and molecular diagnostics reveal substantial diagnostic shifts in pediatric melanocytic tumors. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. https://doi.org/10.1111/ddg.70541

Vancouver

Abele M, Hahn M, Metzler G, Graeßner U, Haar M, Eigentler TK, et al. Integrated histopathological and molecular diagnostics reveal substantial diagnostic shifts in pediatric melanocytic tumors. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2026. doi:10.1111/ddg.70541

BibTeX
@article{Abele2026,
  author = {Abele, Michael and Hahn, Matthias and Metzler, Gisela and Graeßner, Ulla and Haar, Maja and Eigentler, Thomas K and Forschner, Andrea and Ballin, Nadja and Schroeder, Christopher and Schneider, Dominik T and Brecht, Ines B and Forchhammer, Stephan},
  title = {Integrated histopathological and molecular diagnostics reveal substantial diagnostic shifts in pediatric melanocytic tumors},
  journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
  year = {2026},
  doi = {10.1111/ddg.70541}
}
Kostenlos starten →